Magee Thomson Investment Partners’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q1 | $1K | Sell |
10
-5
| -33% | -$500 | ﹤0.01% | 70 |
|
2016
Q4 | $1K | Sell |
15
-7
| -32% | -$467 | ﹤0.01% | 73 |
|
2016
Q3 | $2K | Sell |
22
-4
| -15% | -$364 | ﹤0.01% | 30 |
|
2016
Q2 | $1K | Sell |
26
-58
| -69% | -$2.23K | ﹤0.01% | 66 |
|
2016
Q1 | $4K | Hold |
84
| – | – | ﹤0.01% | 73 |
|
2015
Q4 | $8K | Buy |
84
+11
| +15% | +$1.05K | ﹤0.01% | 34 |
|
2015
Q3 | $5K | Buy |
73
+17
| +30% | +$1.16K | ﹤0.01% | 57 |
|
2015
Q2 | $5K | Sell |
56
-109
| -66% | -$9.73K | ﹤0.01% | 73 |
|
2015
Q1 | $8K | Buy |
+165
| New | +$8K | ﹤0.01% | 40 |
|